You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV integrase

Showing 1 - 25 of 8,142
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hiv Trial in Nice (plasma inflammatory markers, CD4/CD8 ratio)

Not yet recruiting
  • Hiv
  • plasma inflammatory markers
  • CD4/CD8 ratio
  • Nice, France
    CHU Nice
Jan 16, 2023

HIV I Infection, Cardiovascular Risk Factor, Lipid Metabolism Disorders Trial (Doravirine 100 Mg)

Recruiting
  • HIV I Infection
  • +2 more
  • Doravirine 100 Mg
  • Los Angeles, California
  • +1 more
Nov 1, 2022

Gut Microbiota, PGx and INSTIs Response

Recruiting
  • HIV Infections
  • Brussels, Belgium
    Cliniques universitaires Saint-Luc
Jan 16, 2023

HIV Reservoir, Inflammation and Microbiota Footprint of PLWH

Recruiting
  • HIV Infections
  • Stool sampling
  • Blood plasma collection
  • Marseille, France
    Hôpital Européen Marseille
Jul 26, 2022

Metabolic Effects, Weight Gain, HIV Trial run by the National Institute of Allergy and Infectious Diseases (NIAID) (Tenofovir

Not yet recruiting
  • Metabolic Effects
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

HIV Trial in Baltimore (Switch to Maraviroc + Raltegravir or Dolutegravir)

Completed
Has Results
  • HIV
  • Switch to Maraviroc + Raltegravir or Dolutegravir
  • Baltimore, Maryland
    University of Maryland, Institute of Human Virology
Oct 5, 2021

Human Immunodeficiency Virus Trial in Oakland Park (Symtuza)

Terminated
  • Human Immunodeficiency Virus
  • Oakland Park, Florida
    Midland Research Group, Inc
Dec 3, 2021

HIV Trial in Hangzhou, Beijing, Shanghai (Oral CAB, CAB LA)

Completed
Has Results
  • HIV Infections
  • Oral CAB
  • CAB LA
  • Hangzhou, Zhejiang, China
  • +2 more
May 12, 2021

Hiv, Weight Gain Trial in Toronto (DOR/3TC/TDF)

Enrolling by invitation
  • Hiv
  • Weight Gain
  • Toronto, Ontario, Canada
    University Health Network
May 17, 2022

HIV-1-infection, Multi-Antiviral Resistance Trial in Milan (REGISTER CREATION)

Recruiting
  • HIV-1-infection
  • Multi-Antiviral Resistance
  • REGISTER CREATION
  • Milan, MI, Italy
    Ospedale San Raffaele
Dec 22, 2021

HIV Trial in Worldwide (GSK1265744 Tablets, Injectable GSK1265744, Placebo for GSK1265744 Tablets)

Completed
Has Results
  • HIV Infections
  • GSK1265744 Tablets
  • +3 more
  • Los Angeles, California
  • +7 more
Oct 14, 2021

HIV-1-infection Trial in Kenya (Dolutegravir)

Completed
  • HIV-1-infection
  • Kiambu, Kenya
  • +3 more
Jan 26, 2022

HIV Trial in United States (Doravirine 100 Mg, Tenofovir alafenamide/emtricitabine, tenofovir alafenamide/lamivudine)

Recruiting
  • HIV Infections
  • Doravirine 100 Mg
  • +5 more
  • Birmingham, Alabama
  • +22 more
Feb 22, 2022

HIV I Infection, Adiposity Trial in Saint Louis (Frequently sampled glucose tolerance testing, abdominal subcutaneous adipose

Recruiting
  • HIV I Infection
  • Adiposity
  • Frequently sampled glucose tolerance testing
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jun 15, 2022

HIV/AIDS Trial in Worldwide (Biktarvy, Symtuza)

Recruiting
  • HIV/AIDS
  • Antwerp, Belgium
  • +47 more
Jan 9, 2023

HIV Trial in Worldwide (Placebo for maraviroc (MVC), Placebo for dolutegravir (DTG), Dolutegravir (DTG))

Completed
Has Results
  • HIV Infections
  • Placebo for maraviroc (MVC)
  • +3 more
  • Los Angeles, California
  • +29 more
Apr 20, 2022

HIV Trial in United States (Raltegravir (MK-0518), Placebo)

Completed
Has Results
  • HIV Infections
  • Raltegravir (MK-0518)
  • Placebo
  • Birmingham, Alabama
  • +19 more
Nov 2, 2021

HIV-1-infection, Antiviral Drug Adverse Reaction, Vascular Diseases Trial in Augusta (Dolutegravir 50 MG, Antiretroviral/Anti

Unknown status
  • HIV-1-infection
  • +7 more
  • Dolutegravir 50 MG
  • Antiretroviral/Anti HIV
  • Augusta, Georgia
    Augusta University
Jan 11, 2021

HIV Infection Trial in Worldwide (DTG +DRV/r, SOC)

Completed
  • HIV Infection
  • Buenos Aires, Argentina
  • +30 more
Mar 25, 2021

Bictegravir in the Elderly Living With HIV (BICEP)

Active, not recruiting
  • HIV-1-infection
  • Bictegravir/Emtricitabine/Tenofovir Alafenamide 50 MG-200 MG-25 MG Oral Tablet [BIKTARVY]
  • Buffalo, New York
    Evergreen Health
Oct 28, 2022

Primary Resistance in HIV Patients in Colombia

Recruiting
  • HIV Infection
  • HIV-1 plasma RNA Genotyping secuencing by Sanger technique
  • HIV-1 plasma RNA Genotyping secuencing by Ultra-deep sequencing technique
  • Cali, Valle, Colombia
    REVIVA, Red de VIH del Valle del Cauca
Jan 17, 2022

Intensive Viral Dynamics Substudy of A5248

Completed
  • HIV Infections
  • Treatment Naive
    • Aurora, Colorado
    • +5 more
    Oct 28, 2021

    Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK1349572, Raltegravir, GSK1349572 Placebo)

    Completed
    Has Results
    • Infection, Human Immunodeficiency Virus
    • HIV Infections
    • Birmingham, Alabama
    • +180 more
    Mar 14, 2022

    HIV-1-infection Trial (Delstrigo, KOCITAF)

    Not yet recruiting
    • HIV-1-infection
    • (no location specified)
    Jun 20, 2023

    NNRTI or INSTI on Nonalcoholic Steatosis in HIV/AIDS Patients

    Not yet recruiting
    • Nonalcoholic Fatty Liver Disease
    • +3 more
      • (no location specified)
      Apr 18, 2022